Nebraska Lawsuit Claims NuvaRing Caused Woman’s Death
The estate of a woman who died while using the birth control NuvaRing is suing the manufacturer, claiming the contraceptive caused the woman’s deadly blood clot. The lawsuit was filed in U.S. District Court in Omaha, Nebraska on July 19, 2010 and claims that 43-year-old Ann Tompkins died in February 2009 after using NuvaRing for five months.
The suit seeks damages from pharmaceutical companies who at one or another manufactured the birth control device. Named in the suit are Merck & Co, which acquired former maker Schering-Plough; Organon BioSciences NV, and Akzo Nobel NV. The lawsuit alleges that the manufacturer did not provide enough warning about the risks of blood clots to users of NuvaRing. The amount of damages being sought is not known; this is the first NuvaRing case is Nebraska to date.
Ms. Tomkins, a mother of two, was found dead in her home on February 23, 2009; an autopsy revealed the cause of death as a blood clot in one of her lungs. NuvaRing has been on the market since 2002 and is inserted into the vagina and left there for three weeks each month slowly releasing hormones into the vaginal wall to prevent pregnancy.
If you or a loved one has been harmed by a defective drug anywhere in the United States, please contact the experienced pharmaceutical liability attorneys at Schlichter, Bogard & Denton today to schedule a confidential, no-cost consultation so we may hear the details of your case.